Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACT2: Chelation therapy and vitamins in diabetic post-MI patients
NCT02733185Phase 3Completed
- Sponsor
- Mount Sinai Medical Center
- Start
- Oct 2016
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of edetate disodium in myocardial infarction (MI), sponsored by Mount Sinai Medical Center. Started Oct 2016; status: completed.
02
Drugs
edetate disodium
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02733185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733185.